124 results
Page 2 of 7
8-K
rk7y83 1h
19 Jan 24
Liquidia Corporation Announces Updates to Operations Leadership
7:01am
8-K
EX-99.2
4rv5hhdjm04ms ro
8 Jan 24
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
4:15pm
8-K
EX-99.1
bxaqmm7a
8 Jan 24
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
4:15pm
8-K
bt2igtwi5wryw l7d8n5
4 Jan 24
Liquidia Corporation Announces $100 Million in New Financings
9:37pm
8-K
EX-99.1
8gopcm5b68cv
4 Jan 24
Liquidia Corporation Announces $100 Million in New Financings
9:37pm
8-K
EX-99.1
ar6dctg1rbo1w 4g
20 Dec 23
Other Events
5:16pm
8-K
EX-1.1
037sk4wt38ka 54zqz0x
14 Dec 23
Unregistered Sales of Equity Securities
4:02pm
424B2
3lvf5rd5
12 Dec 23
Prospectus for primary offering
4:41pm
8-K
EX-99.1
yq91tv 5q83ieh9
12 Dec 23
Liquidia Announces Pricing of Public Offering of Common Stock
8:44am
8-K
EX-99.1
6pqz8
7 Nov 23
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:36am
8-K
EX-99.1
bim35r
25 Sep 23
Other Events
5:00pm
8-K
EX-99.1
u74x ence61uhk6sc
6 Sep 23
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
4:37pm
8-K
EX-99.1
4uzzrot
10 Aug 23
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:00am
8-K
EX-99.1
ul5 qw2fkzgiu5wkl89c
27 Jul 23
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
6:00am